Literature DB >> 34299089

Role of Extracellular Vimentin in Cancer-Cell Functionality and Its Influence on Cell Monolayer Permeability Changes Induced by SARS-CoV-2 Receptor Binding Domain.

Divyendu Goud Thalla1,2, Philipp Jung3, Markus Bischoff3,4, Franziska Lautenschläger2,4.   

Abstract

The cytoskeletal protein vimentin is secreted under various physiological conditions. Extracellular vimentin exists primarily in two forms: attached to the outer cell surface and secreted into the extracellular space. While surface vimentin is involved in processes such as viral infections and cancer progression, secreted vimentin modulates inflammation through reduction of neutrophil infiltration, promotes bacterial elimination in activated macrophages, and supports axonal growth in astrocytes through activation of the IGF-1 receptor. This receptor is overexpressed in cancer cells, and its activation pathway has significant roles in general cellular functions. In this study, we investigated the functional role of extracellular vimentin in non-tumorigenic (MCF-10a) and cancer (MCF-7) cells through the evaluation of its effects on cell migration, proliferation, adhesion, and monolayer permeability. Upon treatment with extracellular recombinant vimentin, MCF-7 cells showed increased migration, proliferation, and adhesion, compared to MCF-10a cells. Further, MCF-7 monolayers showed reduced permeability, compared to MCF-10a monolayers. It has been shown that the receptor binding domain of SARS-CoV-2 spike protein can alter blood-brain barrier integrity. Surface vimentin also acts as a co-receptor between the SARS-CoV-2 spike protein and the cell-surface angiotensin-converting enzyme 2 receptor. Therefore, we also investigated the permeability of MCF-10a and MCF-7 monolayers upon treatment with extracellular recombinant vimentin, and its modulation of the SARS-CoV-2 receptor binding domain. These findings show that binding of extracellular recombinant vimentin to the cell surface enhances the permeability of both MCF-10a and MCF-7 monolayers. However, with SARS-CoV-2 receptor binding domain addition, this effect is lost with MCF-7 monolayers, as the extracellular vimentin binds directly to the viral domain. This defines an influence of extracellular vimentin in SARS-CoV-2 infections.

Entities:  

Keywords:  IGF-1 receptor; SARS-CoV-2 receptor binding domain; cancer; extracellular vimentin

Year:  2021        PMID: 34299089     DOI: 10.3390/ijms22147469

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  10 in total

1.  Extracellular Vimentin as a Target Against SARS-CoV-2 Host Cell Invasion.

Authors:  Łukasz Suprewicz; Maxx Swoger; Sarthak Gupta; Ewelina Piktel; Fitzroy J Byfield; Daniel V Iwamoto; Danielle Germann; Joanna Reszeć; Natalia Marcińczyk; Robert J Carroll; Paul A Janmey; J M Schwarz; Robert Bucki; Alison E Patteson
Journal:  Small       Date:  2021-12-05       Impact factor: 15.153

Review 2.  Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases.

Authors:  Ranu Surolia; Veena B Antony
Journal:  Front Cell Dev Biol       Date:  2022-04-28

3.  Recent Advances in Intermediate Filaments-Volume 1.

Authors:  Angela Saez; Jose M Gonzalez-Granado
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

4.  Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19.

Authors:  Prasenohadi Prasenohadi; Erlina Burhan; Sri Dhunny; Wahyuningsih Suharno; Paul Wabnitz; Yoon-Won Kim; Nicola Petrosillo
Journal:  J Clin Med       Date:  2022-05-24       Impact factor: 4.964

5.  Exogenous Vimentin Supplementation Transiently Affects Early Steps during HPV16 Pseudovirus Infection.

Authors:  Sinead Carse; Dirk Lang; Arieh A Katz; Georgia Schäfer
Journal:  Viruses       Date:  2021-12-10       Impact factor: 5.048

Review 6.  SARS-CoV-2: Receptor and Co-receptor Tropism Probability.

Authors:  Narges Eslami; Parisa Shiri Aghbash; Ali Shamekh; Taher Entezari-Maleki; Javid Sadri Nahand; Abolfazl Jafari Sales; Hossein Bannazadeh Baghi
Journal:  Curr Microbiol       Date:  2022-03-16       Impact factor: 2.343

Review 7.  Impact of Vimentin on Regulation of Cell Signaling and Matrix Remodeling.

Authors:  Zofia Ostrowska-Podhorodecka; Isabel Ding; Masoud Norouzi; Christopher A McCulloch
Journal:  Front Cell Dev Biol       Date:  2022-03-11

8.  Vimentin Inhibits Dengue Virus Type 2 Invasion of the Blood-Brain Barrier.

Authors:  Jianhai Yu; Xujuan Li; Dongrui Zhou; Xuling Liu; Xiaoen He; Sheng-He Huang; Qinghua Wu; Li Zhu; Linzhong Yu; Jinxiu Yao; Bao Zhang; Wei Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-03-30       Impact factor: 6.073

9.  SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells.

Authors:  Hoai-Nga Thi Nguyen; Marie Kawahara; Cat-Khanh Vuong; Mizuho Fukushige; Toshiharu Yamashita; Osamu Ohneda
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

10.  Extracellular vimentin is expressed at the rear of activated macrophage-like cells: Potential role in enhancement of migration and phagocytosis.

Authors:  Divyendu Goud Thalla; Ashish Chand Rajwar; Annalena Maria Laurent; Johanna Elisabeth Becher; Lucina Kainka; Franziska Lautenschläger
Journal:  Front Cell Dev Biol       Date:  2022-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.